A structured framework covering HIPAA liability, reimbursement sustainability, technology ownership, and payer contract integrity for $1M–$5M digital health acquisitions.
Find Telehealth Platform Acquisition TargetsAcquiring a telehealth platform requires evaluating clinical compliance, recurring revenue durability, and technology scalability simultaneously. Buyers must assess HIPAA exposure, payer contract terms, and provider network transferability before closing on any digital health asset in the lower middle market.
Assess HIPAA infrastructure, data security history, state licensing, and prescribing authority compliance before progressing to financial or technical diligence.
Obtain the most recent third-party HIPAA security risk assessment and verify all Business Associate Agreements are executed with vendors, payers, and health system clients.
Confirm the platform holds required state telehealth licenses and that all prescribing clinicians hold valid licenses in states where patients are served.
Review HHS Office for Civil Rights correspondence, any prior breach notifications, and state attorney general inquiries for unresolved compliance liabilities.
Validate ARR composition, reimbursement model durability, and customer concentration to confirm revenue quality and forward-looking sustainability.
Review all payer contracts, Medicare Advantage agreements, and direct-to-employer contracts. Identify any revenue dependent on COVID-era emergency use authorizations that may not renew.
Identify any client representing more than 40% of ARR. Request cohort-level churn data and NPS scores to assess patient and health system retention trends.
Confirm 70%+ gross margins by reconciling provider costs, platform hosting, and clinical operations expenses against reported financials.
Evaluate IP ownership, EHR integration complexity, technology debt, and founder dependency before finalizing deal structure and transition planning.
Confirm all source code is company-owned with signed IP assignment agreements. Flag offshore development without proper assignment or undocumented third-party libraries.
Assess existing EHR integrations, API dependencies, and infrastructure architecture for scalability. Identify technical debt that could increase post-close integration costs.
Determine whether clinical relationships, platform access, or payer negotiations are personally tied to the seller. Evaluate the clinical operations team's ability to run independently.
Verify the Telehealth Platform acquisition qualifies for SBA financing, the purchase price is supportable by the verified cash flow, and the deal structure protects the buyer's downside.
Confirm the Telehealth Platform meets SBA 7(a) eligibility requirements: the business is for-profit, U.S.-based, within SBA size standards, and the buyer meets personal financial requirements. Some industries have specific SBA restrictions — verify before LOI.
Model verified normalized EBITDA against projected SBA loan payments at current rates. A $1M SBA 7(a) loan at 10.5% over 10 years costs approximately $13,000/month. The Telehealth Platform must generate at least 1.25x debt service coverage after a market-rate manager salary to pass underwriting.
Confirm the seller note is properly subordinated to the SBA loan and goes on 24-month standby as required by SBA rules. If an earnout is included, define exact measurement metrics, time period, and dispute resolution process before signing the purchase agreement.
Before signing a Letter of Intent, request these documents from the seller. Missing or incomplete items are a red flag — not a reason to proceed without them.
Telehealth platforms are generally not SBA-eligible due to healthcare and technology classification restrictions. Most deals are structured with conventional financing, equity rollover, or seller financing with earnout provisions tied to ARR milestones.
Lower middle market telehealth platforms with proven ARR typically trade at 3.5x–6x revenue. Platforms with multi-year payer contracts, proprietary clinical workflows, and low churn command the upper end of the range.
Unresolved HIPAA violations and COVID-era reimbursement dependency are the most common deal-killers. Buyers should also scrutinize undocumented source code and any revenue concentration in a single health system client.
Expect 60–90 days for thorough diligence given the dual complexity of healthcare regulatory review and SaaS financial analysis. Regulatory and IP issues discovered late can extend timelines significantly.
More Telehealth Platform Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers